Literature DB >> 18466943

A cell-based in vitro alternative to identify skin sensitizers by gene expression.

Jef Hooyberghs1, Elke Schoeters, Nathalie Lambrechts, Inge Nelissen, Hilda Witters, Greet Schoeters, Rosette Van Den Heuvel.   

Abstract

The ethical and economic burden associated with animal testing for assessment of skin sensitization has triggered intensive research effort towards development and validation of alternative methods. In addition, new legislation on the registration and use of cosmetics and chemicals promote the use of suitable alternatives for hazard assessment. Our previous studies demonstrated that human CD34(+) progenitor-derived dendritic cells from cord blood express specific gene profiles upon exposure to low molecular weight sensitizing chemicals. This paper presents a classification model based on this cell type which is successful in discriminating sensitizing chemicals from non-sensitizing chemicals based on transcriptome analysis of 13 genes. Expression profiles of a set of 10 sensitizers and 11 non-sensitizers were analyzed by RT-PCR using 9 different exposure conditions and a total of 73 donor samples. Based on these data a predictive dichotomous classifier for skin sensitizers has been constructed, which is referred to as VITOSENS. In a first step the dimensionality of the input data was reduced by selectively rejecting a number of exposure conditions and genes. Next, the generalization of a linear classifier was evaluated by a cross-validation which resulted in a prediction performance with a concordance of 89%, a specificity of 97% and a sensitivity of 82%. These results show that the present model may be a useful human in vitro alternative for further use in a test strategy towards the reduction of animal use for skin sensitization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466943     DOI: 10.1016/j.taap.2008.03.014

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

Review 1.  Application of proteomics in the elucidation of chemical-mediated allergic contact dermatitis.

Authors:  Tessa Höper; Franz Mussotter; Andrea Haase; Andreas Luch; Tewes Tralau
Journal:  Toxicol Res (Camb)       Date:  2017-06-13       Impact factor: 3.524

2.  A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests.

Authors:  Henrik Johansson; Malin Lindstedt; Ann-Sofie Albrekt; Carl A K Borrebaeck
Journal:  BMC Genomics       Date:  2011-08-08       Impact factor: 3.969

Review 3.  Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany.

Authors:  M Peiser; T Tralau; J Heidler; A M Api; J H E Arts; D A Basketter; J English; T L Diepgen; R C Fuhlbrigge; A A Gaspari; J D Johansen; A T Karlberg; I Kimber; J P Lepoittevin; M Liebsch; H I Maibach; S F Martin; H F Merk; T Platzek; T Rustemeyer; A Schnuch; R J Vandebriel; I R White; A Luch
Journal:  Cell Mol Life Sci       Date:  2011-10-14       Impact factor: 9.261

4.  Transcriptional profiling of human dendritic cell populations and models--unique profiles of in vitro dendritic cells and implications on functionality and applicability.

Authors:  Kristina Lundberg; Ann-Sofie Albrekt; Inge Nelissen; Saskia Santegoets; Tanja D de Gruijl; Sue Gibbs; Malin Lindstedt
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

5.  Association of differential gene expression with imatinib mesylate and omacetaxine mepesuccinate toxicity in lymphoblastoid cell lines.

Authors:  Hemant Kulkarni; Harald H H Göring; Vincent Diego; Shelley Cole; Ken R Walder; Greg R Collier; John Blangero; Melanie A Carless
Journal:  BMC Med Genomics       Date:  2012-08-23       Impact factor: 3.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.